Brief: Medicover: Increased ownership in NIPD Genetics
Dec 9 (Reuters) - Medicover AB MCOVb.ST :
* COMMITTED TO INCREASE OWNERSHIP IN NIPD GENETICS ("NIPD")
FROM
18.9% TO 87.2 %
* PURCHASE PRICE FOR 68.3 PER CENT OF ACQUIRED SHARES
AMOUNTS TO
EUR 44.4 MILLION WITH NO DEBT ASSUMED
* TRANSACTION CLOSING IS EXPECTED IN Q1 2022.
Source text for Eikon: ID:nWkrbcJrcy
Further company coverage: MCOVb.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Medicover AB
See all newsSweden's Medicover Q3 profit rises 29% on price adjustments and wider network; to focus on Europe
Brief: Medicover Reports Q3 EBIT Of €49.3 Million
Medicover India hospitals to be profitable in 18 months, eyes 20-25% margins (updated)
Medicover India's 25 hospitals to be profitable in 18 months, executive says
Brief: Medicover Board Member Acquires Shares Worth SEK 23 Mln In Company